RightAnswer Knowledge Solutions provides access to hundreds of data sources. Our premier and proprietary sources include fully-researched documents from well-established experts in the chemical and HazMat fields.
A search in our system for this chemical would return results – all in one place -- in the following categories from the listed data sources.
- Chemical Identification
- Environmental Hazards
- First Aid/Medical Treatment
- Handling/Storage/Shipping/Waste Management
- Personal Protection
- Physical Hazards/Corrective Response Actions
- Physical/Chemical Properties
- Report Abstracts and Studies
- Reproductive Risk
- Toxicology/Health Hazards/Exposure
|Example of Acute Exposure data from MEDITEXT.|
RightAnswer Proprietary Data Sources:
Other Government Links Searched via RegsKnowledge:
State Environmental Regulations
Example Content from MEDITEXT for 61379-65-5:
Please note: this is an extract of information from a larger document. Full document and details are available by subscription.
ACUTE EXPOSURE INFORMATION
- USES: Rifapentine is indicated for the treatment of pulmonary infection caused by Mycobacterium tuberculosis in combination with other antituberculosis agents.
- PHARMACOLOGY: Rifapentine is a cyclopentyl rifamycin derivative antibiotic with bactericidal activity against mycobacterium tuberculosis.
- EPIDEMIOLOGY: Overdose is uncommon.
- WITH THERAPEUTIC USE
- ADVERSE EFFECTS: Red-orange discoloration of body tissues and fluids, including skin, teeth, tongue, urine, feces, saliva, sweat and tears, may commonly occur with therapy. Other reported adverse effects or alterations in laboratory studies include: elevated liver enzyme levels, neutropenia, anemia, lymphopenia, proteinuria, hematuria, hypoglycemia, arthralgias and rash.
- WITH POISONING/EXPOSURE
- OVERDOSE: Information is limited. Administration of 1200 mg as a single oral dose resulted in minor adverse effects including heartburn, headache, and increased urinary frequency.
- MILD TO MODERATE TOXICITY: Nausea, vomiting, anorexia, arthralgias, rash and elevated liver enzymes can develop. Red-orange discoloration of the skin, body tissues and fluids may occur.
- SEVERE TOXICITY: Hepatotoxicity, hyperbilirubinemia, and hematologic toxicity may develop following a significant exposure.
© 2011-2020 RightAnswer.com, Inc. and/or its licensors. All rights reserved. No claim to original U.S. Govt. works.